Adjuvant camrelizumab significantly improves event-free survival in patients with locoregionally advanced nasopharyngeal ...

Two neoadjuvant immunotherapy combinations for head and neck cancer substantially increased the response rate versus a single ...

First and only immunotherapy to show meaningful overall survival benefit in a Phase 2 trial in patients with advanced ovarian cancer Company to hold conference call on Tuesday, March 25, 2025, at 2:00 ...

Targeted inhibition of a "signal jammer" protein may improve how tumors respond to immunotherapy. Published today in Nature, ...

Effective treatments for hay fever include: Intranasal Corticosteroids: These sprays reduce inflammation in the nasal ...

Former U.S. Rep. Mia Love of Utah, a daughter of Haitian immigrants who became the first Black Republican woman elected to ...

A team of researchers from Cleveland Clinic Genomic Medicine share insights from an early set of 19,000 patients to receive ...

Mia Love, the first Black Republican woman elected to the U.S. Congress died at the age of 49 following a battle with brain ...

Lung cancer remains one of the most widespread and deadliest malignant tumors globally, with a particularly high mortality rate among all cancers. Recently, immunotherapy, particularly immune ...

Adding immunotherapy to a new type of inhibitor that targets multiple forms of the cancer-causing gene mutation KRAS kept ...

Researchers have revealed a new finding that could improve cancer care immunotherapy treatments, particularly for CLL and ...

CERo’s technology works by grafting onto patients’ own T-cells a receptor that binds to a naturally occurring human antigen ...